Skip to main content

Table 2 Schedule of assessments for waitlisted group

From: NAV-KIDS2 trial: protocol for a multi-centre, staggered randomised controlled trial of a patient navigator intervention in children with chronic kidney disease

  Screen Random Wait (1mo) Wait (3mo) Start treat Treat (1mo) Treat (3mo) End treat (6mo) Post-treat (6mo) Post-treat (12mo)
Day   0 28 84 168 196 252 336 504 672
Eligibility Criteria x          
Demographics   x         
CKD Information   x x x x x x x x x
Medical History   x x x x x x x x x
Physical Examination   x x x x x x x x x
Bloods   x    x    x x x
Immunosuppressive Medications   x x x x x x x x x
Concomitant Medications   x x x x x x x x x
SRH (Child and Caregiver)   x x x x x x x x x
Educational Background   x         
School Absenteeism   x x x x x x x x x
HUI Questionnaire   x x x x x x x x x
Caregiver Satisfaction Questionnaire (Caregiver)   x x x x x x x x x
Patient Navigator Satisfaction Questionnaire (Caregiver)       x x x   
Adverse events    x x x x x x x x
Hospitalisation    x x x x x x x x
Data linkage (NDI, ANZDATA, MBS, PBS)           x
Qualitative interviews/ questionnaires (subset of participants only)   x      x x x  
  1. Abbreviations. CKD: Chronic kidney disease, SRH: Self-rated health, HUI: Health utilities index, NDI: National death index, ANZDATA: Australia and New Zealand Dialysis and Transplant Registry, MBS: Medicare Benefits Schedule, PBS: Pharmaceutical Benefits Scheme